{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:22:07Z","timestamp":1791872527960,"version":"4.3.4"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,12,27]],"date-time":"2020-12-27T00:00:00Z","timestamp":1609027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Imperial College Medical Research Council Doctoral Training Partnership"},{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002992","name":"Department for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DFID Concordat agreement","award":["MR\/R015600\/1"],"award-info":[{"award-number":["MR\/R015600\/1"]}]},{"name":"National Institute for Health Research-Imperial Biomedical Research Centre"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Progress towards viral hepatitis elimination goals relies on accurate estimates of chronic hepatitis B virus (HBV)-infection prevalence. We compared existing sources of country-level estimates from 2013 to 2017 to investigate the extent and underlying drivers of differences between them.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The four commonly cited sources of global-prevalence estimates, i.e. the Institute for Health Metrics and Evaluation, Schweitzer et al., the World Health Organization (WHO) and the CDA Foundation, were compared by calculating pairwise differences between sets of estimates and assessing their within-country variation. Differences in underlying empirical data and modelling methods were investigated as contributors to differences in sub-Saharan African estimates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The four sets of estimates across all ages were comparable overall and agreed on the global distribution of HBV burden. The WHO and the CDA produced the most similar estimates, differing by a median of 0.8 percentage points. Larger discrepancies were seen in estimates of prevalence in children under 5\u2009years of age and in sub-Saharan African countries, where the median pairwise differences were 2.7 percentage and 2.4 percentage points for all-age prevalence and in children, respectively. Recency and representativeness of included data, and different modelling assumptions of the age distribution of HBV burden, seemed to contribute to these differences.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Current prevalence estimates, particularly those from the WHO and the CDA based on more recent empirical data, provide a useful resource to assess the population-level burden of chronic HBV-infection. However, further seroprevalence data in young children are needed particularly in sub-Saharan Africa. This is a priority, as monitoring progress towards elimination depends on improved knowledge of prevalence in this age group.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ije\/dyaa253","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T12:12:34Z","timestamp":1605528754000},"page":"560-569","source":"Crossref","is-referenced-by-count":59,"title":["The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9840-0878","authenticated-orcid":false,"given":"Nora","family":"Schmit","sequence":"first","affiliation":[{"name":"MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shevanthi","family":"Nayagam","sequence":"additional","affiliation":[{"name":"MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK"},{"name":"Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Thursz","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B","family":"Hallett","sequence":"additional","affiliation":[{"name":"MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,27]]},"reference":[{"key":"2021070900044026600_dyaa253-B1","volume-title":"WHO Global Hepatitis Report","year":"2017"},{"key":"2021070900044026600_dyaa253-B2","doi-asserted-by":"crossref","first-page":"1290370","DOI":"10.1080\/16549716.2017.1290370","article-title":"Global estimates of country health indicators: useful, unnecessary, inevitable?","volume":"10","author":"AbouZahr","year":"2017","journal-title":"Global Health Action"},{"key":"2021070900044026600_dyaa253-B3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S2468-1253(17)30295-9","article-title":"Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets","volume":"2","author":"Spearman","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2021070900044026600_dyaa253-B4","year":"2019"},{"key":"2021070900044026600_dyaa253-B5","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"2021070900044026600_dyaa253-B6","volume-title":"Consolidated Strategic Information Guidelines for Viral Hepatitis: Planning and Tracking Progress towards Elimination","year":"2019"},{"key":"2021070900044026600_dyaa253-B7","year":"2018"},{"key":"2021070900044026600_dyaa253-B8","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.ijid.2010.09.005","article-title":"Seroprevalence of markers for hepatitis B viral infection","volume":"15","author":"Merrill","year":"2011","journal-title":"Int J Infect Dis"},{"key":"2021070900044026600_dyaa253-B9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/jvh.13247","article-title":"Hepatitis B in sub-Saharan Africa: how many patients need therapy?","volume":"27","author":"Sonderup","year":"2020","journal-title":"J Viral Hepat"},{"key":"2021070900044026600_dyaa253-B10","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"2021070900044026600_dyaa253-B11","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"2021070900044026600_dyaa253-B12","year":"2016"},{"key":"2021070900044026600_dyaa253-B13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2021070900044026600_dyaa253-B14","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/ije\/dyy144","article-title":"What is the true tuberculosis mortality burden? Differences in estimates by the World Health Organization and the Global Burden of Disease study","volume":"47","author":"Garcia-Basteiro","year":"2018","journal-title":"Int J Epidemiol"},{"key":"2021070900044026600_dyaa253-B15","doi-asserted-by":"crossref","first-page":"e1001288","DOI":"10.1371\/journal.pmed.1001288","article-title":"Child mortality estimation: a comparison of UN IGME and IHME estimates of levels and trends in under-five mortality rates and deaths","volume":"9","author":"Alkema","year":"2012","journal-title":"PLoS Med"},{"key":"2021070900044026600_dyaa253-B16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12879-014-0728-4","article-title":"Deconstructing the differences: a comparison of GBD 2010 and CHERG\u2019s approach to estimating the mortality burden of diarrhea, pneumonia, and their etiologies","volume":"15","author":"Kovacs","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2021070900044026600_dyaa253-B17","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(15)61132-1","article-title":"Causes of child death: comparison of MCEE and GBD 2013 estimates","volume":"385","author":"Liu","year":"2015","journal-title":"Lancet"},{"key":"2021070900044026600_dyaa253-B18","year":"2017"},{"key":"2021070900044026600_dyaa253-B19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013","volume":"388","author":"Stanaway","year":"2016","journal-title":"Lancet"},{"key":"2021070900044026600_dyaa253-B20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med"},{"key":"2021070900044026600_dyaa253-B21","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S1473-3099(16)30204-3","article-title":"Requirements for global elimination of hepatitis B: a modelling study","volume":"16","author":"Nayagam","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2021070900044026600_dyaa253-B22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1098\/rspb.1993.0102","article-title":"The influence of age on the development of the hepatitis B carrier state","volume":"253","author":"Edmunds","year":"1993","journal-title":"Proc Biol Sci"},{"key":"2021070900044026600_dyaa253-B23","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/ije\/dyz223","article-title":"Ensemble modelling in descriptive epidemiology: burden of disease estimation","volume":"49","author":"Bannick","year":"2019","journal-title":"Int J Epidemiol"},{"key":"2021070900044026600_dyaa253-B24","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"key":"2021070900044026600_dyaa253-B25","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2471\/BLT.18.208603","article-title":"Hepatitis B and C virus seroprevalence, Burkina Faso: a cross-sectional study","volume":"96","author":"Meda","year":"2018","journal-title":"Bull World Health Organ"},{"key":"2021070900044026600_dyaa253-B26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4269\/ajtmh.18-0883","article-title":"Seroepidemiology of hepatitis B in the Democratic Republic of the Congo","volume":"101","author":"Thompson","year":"2019","journal-title":"Am J Trop Med Hyg"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/50\/2\/560\/38883203\/dyaa253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/50\/2\/560\/38883203\/dyaa253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T07:20:57Z","timestamp":1625815257000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article\/50\/2\/560\/6053478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,27]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,12,27]]},"published-print":{"date-parts":[[2021,5,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/dyaa253","relation":{},"ISSN":["0300-5771","1464-3685"],"issn-type":[{"value":"0300-5771","type":"print"},{"value":"1464-3685","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,12,27]]}}}